NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer
With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.
We use necessary cookies to make our site work. We'd also like to set analytical cookies to help us improve our service, but we'd like your permission first. Please choose which cookies you're happy for us to set.